76 related articles for article (PubMed ID: 20619533)
1. Chk1 inhibitor Gö6976 enhances the sensitivity of nasopharyngeal carcinoma cells to radiotherapy and chemotherapy in vitro and in vivo.
Feng Z; Xu S; Liu M; Zeng YX; Kang T
Cancer Lett; 2010 Nov; 297(2):190-7. PubMed ID: 20619533
[TBL] [Abstract][Full Text] [Related]
2. Treatment with the Chk1 inhibitor Gö6976 enhances cisplatin cytotoxicity in SCLC cells.
Thompson R; Meuth M; Woll P; Zhu Y; Danson S
Int J Oncol; 2012 Jan; 40(1):194-202. PubMed ID: 21894433
[TBL] [Abstract][Full Text] [Related]
3. Influence of chk1 and plk1 silencing on radiation- or cisplatin-induced cytotoxicity in human malignant cells.
Gao Q; Huang X; Tang D; Cao Y; Chen G; Lu Y; Zhuang L; Wang S; Xu G; Zhou J; Ma D
Apoptosis; 2006 Oct; 11(10):1789-800. PubMed ID: 16927022
[TBL] [Abstract][Full Text] [Related]
4. Checkpoint Kinase 1 Inhibition Enhances Cisplatin Cytotoxicity and Overcomes Cisplatin Resistance in SCLC by Promoting Mitotic Cell Death.
Hsu WH; Zhao X; Zhu J; Kim IK; Rao G; McCutcheon J; Hsu ST; Teicher B; Kallakury B; Dowlati A; Zhang YW; Giaccone G
J Thorac Oncol; 2019 Jun; 14(6):1032-1045. PubMed ID: 30771522
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel, in vivo active Chk1 inhibitors utilizing structure guided drug design.
Massey AJ; Stokes S; Browne H; Foloppe N; Fiumana A; Scrace S; Fallowfield M; Bedford S; Webb P; Baker L; Christie M; Drysdale MJ; Wood M
Oncotarget; 2015 Nov; 6(34):35797-812. PubMed ID: 26437226
[TBL] [Abstract][Full Text] [Related]
6. Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinoma.
Hui EP; Lui VW; Wong CS; Ma BB; Lau CP; Cheung CS; Ho K; Cheng SH; Ng MH; Chan AT
Invest New Drugs; 2011 Dec; 29(6):1123-31. PubMed ID: 20467883
[TBL] [Abstract][Full Text] [Related]
7. ZD1839 and cisplatin alone or in combination for treatment of a nasopharyngeal carcinoma cell line and Xenografts.
Gu WG; Huang Y; Yuan ZY; Peng RJ; Luo HT; He ZR; Wang SS
Asian Pac J Cancer Prev; 2013; 14(3):1787-90. PubMed ID: 23679274
[TBL] [Abstract][Full Text] [Related]
8. [Radiosensitivity of nasopharyngeal carcinoma in relation to cell cycle synchronization effect of tumor necrosis factor alpha].
Yuan J; Sun N; Wang LJ; Tian W; Zhou XM; Chen DB; Gu HB
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):374-6. PubMed ID: 17425997
[TBL] [Abstract][Full Text] [Related]
9. Nigericin selectively targets cancer stem cells in nasopharyngeal carcinoma.
Deng CC; Liang Y; Wu MS; Feng FT; Hu WR; Chen LZ; Feng QS; Bei JX; Zeng YX
Int J Biochem Cell Biol; 2013 Sep; 45(9):1997-2006. PubMed ID: 23831840
[TBL] [Abstract][Full Text] [Related]
10. Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatin.
Xie SM; Fang WY; Liu Z; Wang SX; Li X; Liu TF; Xie WB; Yao KT
J Transl Med; 2008 Oct; 6():55. PubMed ID: 18834541
[TBL] [Abstract][Full Text] [Related]
11. Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo.
Zhao YY; Tian Y; Zhang J; Xu F; Yang YP; Huang Y; Zhao HY; Zhang JW; Xue C; Lam MH; Yan L; Hu ZH; Dinglin XX; Zhang L
Drug Des Devel Ther; 2014; 8():1827-37. PubMed ID: 25336925
[TBL] [Abstract][Full Text] [Related]
12. Suppression of BCL-2 synergizes cisplatin sensitivity in nasopharyngeal carcinoma cells.
Low SY; Tan BS; Choo HL; Tiong KH; Khoo AS; Leong CO
Cancer Lett; 2012 Jan; 314(2):166-75. PubMed ID: 22033244
[TBL] [Abstract][Full Text] [Related]
13. The preclinical study of predicting radiosensitivity in human nasopharyngeal carcinoma xenografts by 18F-ML-10 animal- PET/CT imaging.
Bao X; Yang Z; Wang S; Zheng Y; Wang M; Gu B; Zhang J; Zhang Y; Zhang Y
Oncotarget; 2016 Apr; 7(15):20743-52. PubMed ID: 26942701
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of CHK1 kinase by Gö6976 converts 8-chloro-adenosine-induced G2/M arrest into S arrest in human myelocytic leukemia K562 cells.
Jia XZ; Yang SY; Zhou J; Li SY; Ni JH; An GS; Jia HT
Biochem Pharmacol; 2009 Mar; 77(5):770-80. PubMed ID: 19059218
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy.
Zhang JX; Qian D; Wang FW; Liao DZ; Wei JH; Tong ZT; Fu J; Huang XX; Liao YJ; Deng HX; Zeng YX; Xie D; Mai SJ
Cancer Lett; 2013 Feb; 329(1):91-8. PubMed ID: 23142283
[TBL] [Abstract][Full Text] [Related]
16. CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivo.
Tse AN; Rendahl KG; Sheikh T; Cheema H; Aardalen K; Embry M; Ma S; Moler EJ; Ni ZJ; Lopes de Menezes DE; Hibner B; Gesner TG; Schwartz GK
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):591-602. PubMed ID: 17255282
[TBL] [Abstract][Full Text] [Related]
17. MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells.
Wang WJ; Wu SP; Liu JB; Shi YS; Huang X; Zhang QB; Yao KT
Cancer Res; 2013 Feb; 73(3):1219-31. PubMed ID: 23269272
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C inhibitor Gö6976 augments caffeine-induced reversal of chemoresistance to cis-diamminedichloroplatinum-II (CDDP) in a human ovarian cancer model.
Qamar L; Davis R; Anwar A; Behbakht K
Gynecol Oncol; 2008 Sep; 110(3):425-31. PubMed ID: 18619662
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of differential sensitivity to cisplatin in nasopharyngeal carcinoma cells.
Wang X; Masters JR; Wong YC; Lo AK; Tsao SW
Anticancer Res; 2001; 21(1A):403-8. PubMed ID: 11299769
[TBL] [Abstract][Full Text] [Related]
20. The protein kinase C inhibitor Gö6976 is a potent inhibitor of DNA damage-induced S and G2 cell cycle checkpoints.
Kohn EA; Yoo CJ; Eastman A
Cancer Res; 2003 Jan; 63(1):31-5. PubMed ID: 12517773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]